Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A
February 21, 2017 at 14:20 PM EST
Stephen Ubl, the head of the Pharmaceutical Research and Manufacturers of America, visited Boston on Tuesday as part of a public relations campaign aimed at countering criticism of high drug prices.
